VG-3927
AssetAlso called VG‐3927
Activates TREM2 signaling in microglia to promote their protective functions.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- TREM2
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Alzheimer's disease
Phase 1, Completed, NCT06343636, clinicaltrials.gov, Oct 17, 2026
In the full profile
- Target and mechanism1
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors12
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.